Literature DB >> 6261569

Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors.

G Baumann, G Riess, W D Erhardt, S B Felix, L Ludwig, G Blümel, H Blömer.   

Abstract

Left ventricular infarction (AMI) was produced in experimental animals and the contractile response to isoproterenol was tested in the isolated perfused heart preparation. Adenylate cyclase activity, phosphodiesterase activity, and beta-receptor binding characteristics were determined in a sarcolemmal preparation of the right ventricle of the same hearts. Three days post-AMI the dose-response curve for isoproterenol of right ventricular dP/dtmax was significantly depressed, while the inotropic effect of histamine was not impaired. Stimulation of adenylate cyclase activity by isoproterenol was reduced by 70% in the membrane preparation, whereas histamine and NaF stimulation rates were unaltered; phosphodiesterase activity was unchanged. In contrast, beta-receptor binding studies with [3H]-DHA1 indicated 74% loss and 10 times lowered affinity (KD) of the remaining beta-receptors, while specific [3H]-QNB1 binding was unchanged. All of the above alterations were prevented by pretreatment with reserpine or metoprolol. It is concluded that these abnormalities in the nonischemic surviving myocardium post-AMI are the result of specific reversible damage of sarcolemmal beta-receptors due to excessive levels of circulating catecholamines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6261569     DOI: 10.1016/0002-8703(81)90223-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Pharmacologic characterization in vitro and in vivo of iodine 123-labeled derivatives of the beta-adrenoceptor antagonist CGP12177, designed for the imaging of cardiac beta-receptors.

Authors:  E A Dubois; G A Somsen; J C van den Bos; A G Janssen; G J Boer; H D Batink; E A van Royen; M Pfaffendorf; P A van Zwieten
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

2.  Differential regulation of right and left ventricular beta-adrenergic receptors in newborn lambs with experimental cyanotic heart disease.

Authors:  D Bernstein; E Voss; S Huang; R Doshi; C Crane
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Effects of acute ischemia in the dog on myocardial blood flow, beta receptors, and adenylate cyclase activity with and without chronic beta blockade.

Authors:  J S Karliner; M B Stevens; N Honbo; J I Hoffman
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Positive inotropic stimulation in the normal and insufficient human myocardium.

Authors:  E Erdmann; M Böhm
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

5.  Local beta-adrenergic blockade does not reduce infarct size after coronary occlusion and reperfusion: a study of coronary venous retroinfusion of metoprolol.

Authors:  S Kobayashi; H Tadokoro; L Rydén; P O Sjöquist; R V Haendchen; E Corday
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

6.  Local myocardial perfusion and epicardial NADH-fluorescence after coronary artery ligation in the isolated guinea pig heart.

Authors:  R Rösen; A Marsen; W Klaus
Journal:  Basic Res Cardiol       Date:  1984 Jan-Feb       Impact factor: 17.165

Review 7.  Changes in adrenergic receptors during the development of heart failure.

Authors:  N S Dhalla; I M Dixon; S Suzuki; M Kaneko; A Kobayashi; R E Beamish
Journal:  Mol Cell Biochem       Date:  1992-09-08       Impact factor: 3.396

8.  Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium.

Authors:  G Baumann; S B Felix; C D Heidecke; G Riess; U Loher; L Ludwig; H Blömer
Journal:  Agents Actions       Date:  1984-10

9.  Dobutamine: positive inotropy by nonselective adrenoceptor agonism in isolated guinea pig and human myocardium.

Authors:  L Brown; M Näbauer; E Erdmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

10.  Alterations of responsiveness to adrenoceptor agonists and calcium of non-infarcted hypertrophied muscles from rats with chronic myocardial infarction.

Authors:  T Itaya; H Hashimoto; T Uematsu; M Nakashima
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.